Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia

pay.thelady61 shared this article with you from Inoreader Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia Via ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days Condition:   Critical Limb Ischemia Interventions:   Biological: A cluster of adipose-derived mesenchymal stem cells (Dose: 1 x 10^7 cells/1 mL/vial);   Biological: A cluster of adipose-derived mesenchymal stem cells (Dose: 1 x 10^8 cells/1 mL/vial) Sponsors:   S.Biomedics Co., Ltd.;   Dt&Sanomedics Recruiting View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.